• 1
    Sibai BM, Ewell M, Levine RJ, Klebanoff MA, Esterlitz J, Catalano PM, et al. Risk factors associated with preeclampsia in healthy nulliparous women. The Calcium for Preeclampsia Prevention (CPEP) Study Group. Am J Obstet Gynecol 1997;177:100310.
  • 2
    Chang J, Elam-Evans LD, Berg CJ, Herndon J, Flowers L, Seed KA, et al. Pregnancy-related mortality surveillance – United States, 1991–1999. MMWR Surveill Summ 2003;52:18.
  • 3
    Ujah IA, Aisien OA, Mutihir JT, Vanderjagt DJ, Glew RH, Uguru VE. Factors contributing to maternal mortality in north-central Nigeria: a seventeen-year review. Afr J Reprod Health 2005;9:2740.
  • 4
    Waterstone M, Bewley S, Wolfe C. Incidence and predictors of severe obstetric morbidity: case–control study. Br Med J 2001;322:108993; Discussion 1093-94.
  • 5
    Sibai BM, el-Nazer A, Gonzalez-Ruiz A. Severe preeclampsia–eclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol 1986;155:10116.
  • 6
    Lain KY, Roberts JM. Contemporary concepts of the pathogenesis and management of preeclampsia. J Am Med Assoc 2002;287:31836.
  • 7
    Moldenhauer JS, Stanek J, Warshak C, Khoury J, Sibai B. The frequency and severity of placental findings in women with preeclampsia are gestational age dependent. Am J Obstet Gynecol 2003;189:11737.
  • 8
    Sibai BM. Hypertension in pregnancy. In: GabbeSG, NiebylJR, SimpsonJL, editors. Obstetrics: Normal and Problem Pregnancies. New York: Churchill Livingstone; 1996. pp. 93596.
  • 9
    van Rijn BB, Hoeks LB, Bots ML, Franx A, Bruinse HW. Outcomes of subsequent pregnancy after first pregnancy with early-onset preeclampsia. Am J Obstet Gynecol 2006;195:7238.
  • 10
    Ananth CV. Epidemiologic approaches for studying recurrent pregnancy outcomes: challenges and implications for research. Semin Perinatol 2007;31:196201.
  • 11
    Mendilcioglu I, Trak B, Uner M, Umit S, Kucukosmanoglu M. Recurrent preeclampsia and perinatal outcome: a study of women with recurrent preeclampsia compared with women with preeclampsia who remained normotensive during their prior pregnancies. Acta Obstet Gynecol Scand 2004;83:10448.
  • 12
    Caritis S, Sibai B, Hauth J, Lindheimer MD, Klebanoff M, Thom E, et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal–Fetal Medicine Units. N Engl J Med 12 1998;338:7015.
  • 13
    Makkonen N, Heinonen S, Kirkinen P. Obstetric prognosis in second pregnancy after preeclampsia in first pregnancy. Hypertens Pregnancy 2000;19:17381.
  • 14
    Gregory KD, Korst LM. Age and racial/ethnic differences in maternal, fetal, and placental conditions in laboring patients. Am J Obstet Gynecol 2003;188:16026; discussion 1606–8.
  • 15
    Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008;371:7584.
  • 16
    Brown HL, Chireau MV, Jallah Y, Howard D. The ‘Hispanic paradox’: an investigation of racial disparity in pregnancy outcomes at a tertiary care medical center. Am J Obstet Gynecol 2007;197:e1917; discussion e197–9.
  • 17
    Tanaka M, Jaamaa G, Kaiser M, Hills E, Soim A, Zhu M, et al. Racial disparity in hypertensive disorders of pregnancy in New York State: a 10-year longitudinal population-based study. Am J Public Health 2007;97:16370.
  • 18
    Herman AA, McCarthy BJ, Bakewell JM, Ward RH, Mueller BA, Maconochie NE, et al. Data linkage methods used in maternally-linked birth and infant death surveillance data sets from the United States (Georgia, Missouri, Utah and Washington State), Israel, Norway, Scotland and Western Australia. Paediatr Perinat Epidemiol 1997;11(Suppl. 1):522.
  • 19
    Ananth CV, Peltier MR, Chavez MR, Kirby RS, Getahun D, Vintzileos AM. Recurrence of ischemic placental disease. Obstet Gynecol 2007;110:12833.
  • 20
    Kramer MS, Goulet L, Lydon J, Seguin L, McNamara H, Dassa C, et al. Socio-economic disparities in preterm birth: causal pathways and mechanisms. Paediatr Perinat Epidemiol 2001;15(Suppl. 2):10423.
  • 21
    Alexander GR, Kogan MD, Himes JH 1994–1996 U.S. singleton birth weight percentiles for gestational age by race, Hispanic origin, and gender. Matern Child Health J 1999;3:22531.
  • 22
    World Health Organisation. The OBSQUID Project: Quality Development in Perinatal Care – Final Report. Copenhagen: World Health Organization, 1995.
  • 23
    Lain KY, Krohn MA, Roberts JM. Second pregnancy outcomes following preeclampsia in a first pregnancy. Hypertens Pregnancy 2005;24:15969.
  • 24
    Singer JD, Willett JB. Applied Longitudinal Data Analysis: Modeling Change and Event Occurrence. Oxford, NY: Oxford University Press, 2003.
  • 25
    Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004;159:7026.
  • 26
    Spiegelman D, Hertzmark E. Easy SAS calculations for risk or prevalence ratios and differences. Am J Epidemiol 2005;162:199200.
  • 27
    Szklo M, Nieto EJ. Epidemiology. Beyond the Basics, 2nd edn. Gaithersburg, MD: Jones and Bartlett Publishers, 2007.
  • 28
    Brosens I, Dixon HG, Robertson WB. Fetal growth retardation and the arteries of the placental bed. Br J Obstet Gynaecol 1977;84:65663.
  • 29
    Long PA, Abell DA, Beischer NA. Fetal growth retardation and pre-eclampsia. Br J Obstet Gynaecol 1980;87:138.
  • 30
    Easterling TR, Benedetti TJ, Schmucker BC, Millard SP. Maternal hemodynamics in normal and preeclamptic pregnancies: a longitudinal study. Obstet Gynecol 1990;76:10619.
  • 31
    Obed S, Patience A. Birth weight and ponderal index in pre-eclampsia: a comparative study. Ghana Med J 2006;40:813.
  • 32
    Luo ZC, An N, Xu HR, Larante A, Audibert F, Fraser WD. The effects and mechanisms of primiparity on the risk of pre-eclampsia: a systematic review. Paediatr Perinat Epidemiol 2007;21(Suppl. 1):3645.
  • 33
    Sibai B, Dekker G, Kupferminc M. Pre-eclampsia. Lancet 2005;365:78599.
  • 34
    Egbor M, Ansari T, Morris N, Green CJ, Sibbons PD. Morphometric placental villous and vascular abnormalities in early- and late-onset pre-eclampsia with and without fetal growth restriction. BJOG 2006;113:5809.
  • 35
    Ness RB, Sibai BM. Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia. Am J Obstet Gynecol 2006;195:409.
  • 36
    Powers RW, Evans RW, Majors AK, Ojimba JI, Ness RB, Crombleholme WR, et al. Plasma homocysteine concentration is increased in preeclampsia and is associated with evidence of endothelial activation. Am J Obstet Gynecol 1998;1:160511.
  • 37
    Dekker GA, de Vries JI, Doelitzsch PM, Huijgens PC, von Blomberg BM, Jakobs C, et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995;173:10428.
  • 38
    Pouta A, Hartikainen AL, Sovio U, Gissler M, Laitinen J, McCarthy MI, et al. Manifestations of metabolic syndrome after hypertensive pregnancy. Hypertension 2004;43:82531.
  • 39
    Graham J, Zhang L, Schwalberg R. Association of maternal chronic disease and negative birth outcomes in a non-Hispanic Black–White Mississippi birth cohort. Public Health Nurs 2007;24:3117.
  • 40
    Frost F, Starzyk P, George S, McLaughlin JF. Birth complication reporting: the effect of birth certificate design. Am J Public Health 1984;74:5056.